These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 884617)

  • 21. Prejunctional muscarinic receptor modulation of noradrenaline release from sympathetic neurones in rabbit aorta.
    Lomholt M; Nedergaard OA
    Pharmacol Toxicol; 2000 Jun; 86(6):264-9. PubMed ID: 10895989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pyroxamidine and guanethidine on contractile responses to field stimulation and to noradrenaline in the anococcygeus muscle and vas deferens of the rat.
    Doggrell SA
    J Pharm Pharmacol; 1979 Nov; 31(11):767-72. PubMed ID: 41909
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of acute treatment with sibutramine on the sympathetic neurotransmission of the young rat vas deferens.
    de Souza BP; da Silva ED; Jurkiewicz A; Jurkiewicz NH
    Eur J Pharmacol; 2014 Sep; 738():118-24. PubMed ID: 24886880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An adrenergic neuron blocking action of propranolol in isolated tissues.
    Day MD; Owen DA; Warren PR
    J Pharm Pharmacol; 1968 Dec; 20():Suppl:130S+. PubMed ID: 4388146
    [No Abstract]   [Full Text] [Related]  

  • 25. Interactions between guanethidine and inhibitors of noradrenaline uptake.
    Hanahoe TH; Ireson JD; Large BJ
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):349-53. PubMed ID: 5371186
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of nifedipine and ryanodine on adrenergic neurogenic contractions of rat vas deferens: evidence for a pulse-to-pulse change in Ca2+ sources.
    Bültmann R; von Kügelgen I; Starke K
    Br J Pharmacol; 1993 Apr; 108(4):1062-70. PubMed ID: 8485618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoxetine modulates norepinephrine contractile effect on rat vas deferens.
    Busch L; Wald M; Sterin-Borda L; Borda E
    Pharmacol Res; 2000 Jan; 41(1):39-45. PubMed ID: 10600268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens.
    Iversen LL; Langer SZ
    Br J Pharmacol; 1969 Nov; 37(3):627-37. PubMed ID: 5348466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of guanethidine on alpha-adrenoceptor blocking potency of phentolamine in vitro.
    Bhavsar VH; Joshi NJ; Kelkar VV; Patel MP
    Eur J Pharmacol; 1980 Oct; 67(4):489-92. PubMed ID: 6256179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of the sympathomimetic action of guanethidine on the isolated anococcygeus muscle of the rat.
    Foster RW; Shah DS; Small RC
    Br J Pharmacol; 1978 Feb; 62(2):307-13. PubMed ID: 623942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some characteristics of the adrenergic neurone blocking action of dehydroemetine.
    Gulati OD; Makol R; Shah DS
    Br J Pharmacol; 1973 Jun; 48(2):314-7. PubMed ID: 4733732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the interactions of propranolol with adrenergic neurons.
    Saelens DA; Daniell HB; Webb JG
    J Pharmacol Exp Ther; 1977 Sep; 202(3):635-45. PubMed ID: 894526
    [No Abstract]   [Full Text] [Related]  

  • 33. Release of neuropeptide Y (NPY) induced by tyramine in the isolated vas deferens of rat.
    Cheng JT; Shen CL
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):255-60. PubMed ID: 3108675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the effect of cocaine desipramine on the contractions of the isolated vas deferens of the rat induced by dopamine and noradrenaline [proceedings].
    Tayo FM
    West Afr J Pharmacol Drug Res; 1977 Jun; 4(1):74P-75P. PubMed ID: 602198
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancement of H3-norepinephrine accumulation in rat vas deferens by cocaine, imipramine, and desmethylimipramine.
    Maître L; Staehelin M
    Experientia; 1968 Jul; 24(7):671-2. PubMed ID: 5705220
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of the adrenergic effects of orphenadrine in rat vas deferens.
    Pubill D; Canudas AM; Pallàs M; Sureda FX; Escubedo E; Camins A; Camarasa J
    J Pharm Pharmacol; 1999 Mar; 51(3):307-12. PubMed ID: 10344632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular studies of sympathetic denervation produced by 6-hydroxydopamine in the vas deferens.
    Furness JB; Campbell GR; Gillard SM; Malmfors T; Cobb JL; Burnstock G
    J Pharmacol Exp Ther; 1970 Jul; 174(1):111-22. PubMed ID: 4316531
    [No Abstract]   [Full Text] [Related]  

  • 38. Adrenergic and 'non-adrenergic' components in the contractile response of the vas deferens to a single indirect stimulus.
    McGrath JC
    J Physiol; 1978 Oct; 283():23-39. PubMed ID: 31466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of neuronal uptake upon the relative potencies of agonists acting at prejunctional alpha 2-adrenoceptors in the rat isolated vas deferens.
    Warming SE; Shipley SD; Leedham JA; Hartley ML; Handberg GM; Pennefather JN
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):14-30. PubMed ID: 6129831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guanethidine and guanacline on the rat vas deferens.
    Gerkens JF
    Br J Pharmacol; 1974 Oct; 52(2):191-5. PubMed ID: 4451814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.